IPSC CIK: 1850119

Century Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
228
FY22:
320
FY23:
177
FY24:
194
FY25:
121
(positive)
Change from FY21 to FY25
millions USD
FY21:
209
FY22:
167
FY23:
184
FY24:
159
FY25:
103
Total assets
Change from FY21 to FY25
millions USD
FY21:
437
FY22:
487
FY23:
361
FY24:
353
FY25:
224

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
15.7
FY22:
29.8
FY23:
17.8
FY24:
130
FY25:
20.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
25.5
FY22:
154
FY23:
158
FY24:
62.1
FY25:
44.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
396
FY22:
303
FY23:
185
FY24:
161
FY25:
159
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
437
FY22:
487
FY23:
361
FY24:
353
FY25:
224

All amounts in millions USD Data source:SEC EDGAR